Home > Insider Trading > Filing (0001474064-13-000064)

Filing Details

Accession Number:: 0001474064-13-000064
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-10 18:19:30
Reporting Period:: 2013-04-08

Filing Date:: 2013-04-10
Accepted Time:: 2013-04-10 18:19:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365343	Francois Nader	550 Hills Drive Bedminster NJ 07921	President, Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-08	35,644	$5.73	272,504	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	7,632	$4.07	280,136	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	7,100	$4.50	287,236	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	6,567	$4.37	293,803	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	6,104	$4.31	299,907	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	55,470	$4.13	355,377	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	16,125	$4.42	371,502	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	15,358	$4.29	386,860	No	4	M	Direct
Common Stock	Disposition	2013-04-08	150,000	$11.01	236,860	No	4	S	Direct
Common Stock	Acquisiton	2013-04-09	79,356	$4.29	316,216	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	15,000	$4.10	331,216	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	13,875	$3.93	345,091	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	41,769	$3.85	386,860	No	4	M	Direct
Common Stock	Disposition	2013-04-09	150,000	$11.27	236,860	No	4	S	Direct
Common Stock	Acquisiton	2013-04-10	58,231	$3.85	295,091	No	4	M	Direct
Common Stock	Acquisiton	2013-04-10	16,754	$3.60	311,845	No	4	M	Direct
Common Stock	Acquisiton	2013-04-10	54,000	$3.34	365,845	No	4	M	Direct
Common Stock	Disposition	2013-04-10	148,367	$11.68	217,478	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2013-04-08	35,644	$0.00	35,644	$5.73
Common Stock	Stock Option	Disposition	2013-04-08	7,632	$0.00	7,632	$4.07
Common Stock	Stock Option	Disposition	2013-04-08	7,100	$0.00	7,100	$4.50
Common Stock	Stock Option	Disposition	2013-04-08	6,567	$0.00	6,567	$4.37
Common Stock	Stock Option	Disposition	2013-04-08	6,104	$0.00	6,104	$4.31
Common Stock	Stock Option	Disposition	2013-04-08	55,470	$0.00	55,470	$4.13
Common Stock	Stock Option	Disposition	2013-04-08	16,125	$0.00	16,125	$4.42
Common Stock	Stock Option	Disposition	2013-04-08	15,358	$0.00	15,358	$4.29
Common Stock	Stock Option	Disposition	2013-04-09	79,356	$0.00	79,356	$4.29
Common Stock	Stock Option	Disposition	2013-04-09	15,000	$0.00	15,000	$4.10
Common Stock	Stock Option	Disposition	2013-04-09	13,875	$0.00	13,875	$3.93
Common Stock	Stock Option	Disposition	2013-04-09	41,769	$0.00	41,769	$3.85
Common Stock	Stock Option	Disposition	2013-04-10	58,231	$0.00	58,231	$3.85
Common Stock	Stock Option	Disposition	2013-04-10	16,754	$0.00	16,754	$3.60
Common Stock	Stock Option	Disposition	2013-04-10	54,000	$0.00	54,000	$3.34

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
64,356	2016-06-05	No	4	M	Direct
1,243	2016-07-17	No	4	M	Direct
1,775	2016-10-16	No	4	M	Direct
2,308	2017-01-16	No	4	M	Direct
2,771	2017-04-16	No	4	M	Direct
9,030	2017-07-02	No	4	M	Direct
2,625	2017-07-16	No	4	M	Direct
79,356	2017-09-10	No	4	M	Direct
0	2017-09-10	No	4	M	Direct
3,750	2017-10-15	No	4	M	Direct
4,875	2018-01-15	No	4	M	Direct
58,231	2018-03-17	No	4	M	Direct
0	2018-03-17	No	4	M	Direct
5,746	2018-04-15	No	4	M	Direct
54,000	2020-02-19	No	4	M	Direct

Footnotes

The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective November 28, 2012.
Includes 734 shares of stock obtained through Issuer's Employee Stock Purchase Plan on 3/31/13.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was 11.00 and 11.04. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was 11.25 and 11.39. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was 11.65 and 11.71. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
On June 5, 2006, the Reporting Person received a grant of 100,000 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On July 17, 2006, the Reporting Person received a grant of 8,875 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On October 16, 2006, the Reporting Person received a grant of 8,875 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On January 16, 2007, the Reporting Person received a grant of 8,875 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On April 16, 2007, the Reporting Person received a grant of 8,875 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On July 2, 2007, the Reporting Person received a grant of 64,500 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On July 16, 2007, the Reporting Person received a grant of 18,750 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On September 10, 2007, the Reporting Person received a grant of 94,714 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant, 25% on the second anniversary of the date of grant, and 50% on the third anniversary of the date of grant.
On October 15, 2007, the Reporting Person received a grant of 18,750 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On January 15, 2008, the Reporting Person received a grant of 18,750 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On March 17, 2008, the Reporting Person received a grant of 100,000 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On April 15, 2008, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On December 21, 2012, the performance criteria for 54,000 of these options was satisfied when the FDA unanimously voted to approve the NDA for GATTEX for the treatment of SBS. These options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.